Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial

299

Citations

30

References

2014

Year

Adriana H. Tremoulet, Sonia Jain, Preeti Jaggi, Susan Jimenez-Fernandez, Joan Pancheri, Xiaoying Sun, John T. Kanegaye, John P. Kovalchin, Beth F. Printz, Octavio Ramilo,

RheumatologyPrimary TherapyImmunologyMedicineKawasaki DiseasePhase 3

References

	Year	Citations

Page 1